CELL MARQUE CORP

CELL MARQUE CORP specializes in the manufacturing of in-vitro diagnostic substances, with a demonstrated focus on antibody-based reagents for biomedical applications. Their technical expertise lies in the development and production of highly specific monoclonal and polyclonal antibodies used in clinical diagnostics, research assays, and immunohistochemical staining protocols. The company’s capabilities include antigen design, hybridoma development, purification processes, and quality control validation under GMP-aligned standards, ensuring consistency and reliability for critical diagnostic workflows. Their specialization in CELL MARQUE antibodies suggests a niche focus on targeted molecular detection systems, likely supporting pathology labs, defense medical research, and diagnostic kit integration. The contractor has delivered products to the Department of Defense, indicating direct support for military medical readiness, battlefield diagnostics, and infectious disease surveillance programs. This relationship implies alignment with DoD’s medical countermeasure initiatives and biodefense research needs, where rapid, stable, and high-specificity reagents are essential for field-deployable testing platforms. Cell Marque Corp operates within the 325413 NAICS category, which encompasses the manufacturing of reagents and substances used for laboratory-based disease detection. This positions them in the life sciences supply chain, serving clinical, research, and defense sectors that require validated diagnostic components. Their market niche is defined by precision antibody manufacturing rather than broad diagnostic instrumentation, distinguishing them from system integrators or assay developers. As a small business entity structured as a 2L firm based in Rocklin, California, Cell Marque Corp maintains a focused, specialized footprint in the federal biomedical supply market. While no formal government certifications are listed, their ability to secure DoD contracts suggests adherence to stringent quality and regulatory standards required for defense medical procurement. Their geographic location supports access to West Coast biotech ecosystems and federal research hubs.